DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

INSMED, INC. (NASDAQ: INSM)

23.25 -0.21 (-0.90%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INSM $23.25 -0.90%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $23.67
Previous Close $23.46
Daily Range $23.19 - $24.00
52-Week Range $11.25 - $24.00
Market Cap $1.2B
P/E Ratio -12.75
Dividend (Yield) $0.00 (0.0%)
Volume 517,977
Average Daily Volume 619,225
Current FY EPS -$2.07

Sector

Healthcare

Industry

Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website: http://www.insmed.com/

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Use Options For a Chance To Buy INSM at a 55% Discount

Morning Market Losers

Benzinga's Top #PreMarket Losers

Books-A-Million, HomeAway, Vaalco Energy Lead Monday's After-Hours Movers

Should You Buy Insmed Incorporated Ahead of Earnings? - Tale of the Tape

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

5 Red-Hot Biotech Stocks to Buy

See More INSM News...

INSM's Top Competitors

INSM $23.25 (-0.90%)
Current stock: INSM
AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
BIIB $401.71 (-6.64%)
Current stock: BIIB